Rebalix
Logo UBSUBS · sheet of 20 October 2026
ETF sheet · official issuer and register data

UBS Core MSCI World UCITS ETF hEUR acc

WRDE · IE000TB15RC6 · EUR · domicile Ireland
Equity · GlobalEUR-hedged share classSFDR art. 6
Index tracked: MSCI World 100% hedged to EUR Index
TER
0.09%+ trans. 0.00%
Fund size
910 m EUR
Tracking difference
—not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical (full replication)
Income
Accumulating
Launch 24 Apr 2024 · costs from the KID as of 2 Oct 2026 · 1,180 securities held · 10 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 5 Aug 2026
The Fund is passively managed and seeks to track performance of the MSCI World Index (Net Return) (the 'Index'). The Index is designed to measure the performance of mid and large capitalization companies which are listed on worldwide markets. The Fund will seek to hold all of the shares of the Index, in the same proportions as the Index, so that essentially the portfolio of the Fund will be a near mirror image of the Index. In seeking to implement its investment objective of tracking the performance of the Index, the Fund may also in exceptional…

Performance since series start (in euro) — base 100

24 Apr 2024 → 16 Oct 2026 · dividends reinvested where declared by the issuer
2025202614998146
High 149 (13 Aug 2026) · low 98 (8 Apr 2025) · last 146. Past performance is not indicative of future results.

Returns in euro

1 year+14.5%
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+46.3%

Risk · 1 / 3 / 5 years

Volatility (ann.)11.13%11.13%—
Max drawdown−8.44%−8.44%—
Sharpe1.121.12—
Sortino1.661.66—
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · WRDE · IE000TB15RC61
RebalixWRDE · IE000TB15RC6 · sheet of 20 October 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+16.71%+16.74%−0.03%

Holdings

Portfolio as declared by the issuer · 30 Sept 2026 · 1,180 securities · top-10 weight = 28.1%
Top holdingsWeight
NVIDIA CORP5.9%
APPLE INC5.5%
MICROSOFT CORP4.0%
AMAZON.COM INC2.7%
ALPHABET INC-CL A2.3%
META PLATFORMS INC-CLASS A1.8%
ALPHABET INC-CL C1.8%
BROADCOM INC1.8%
MICRON TECHNOLOGY INC1.3%
TESLA INC1.1%
Countries (% of fund)
Stati Uniti72.0%Giappone5.7%Regno Unito3.6%Canada3.4%Francia2.4%
Sectors (% of fund)
Informatica28.9%Finanza16.8%Industriali11.5%Salute9.2%Beni di consumo9.0%

Listing venues

ESMA register (FIRDS) and official exchange lists
WRDE · Borsa Italiana (ETFplus), SIX Swiss Exchange
BCFI · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 6 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.ubs.com/2/e/priip/PRIIPSEU_IE000TB15RC6_en_IE.pdf
Factsheet · www.ubs.com/2/e/files/RET/FS_RET_IE000TB15RC6_IT_IT.pdf
Prospectus · www.ubs.com/2/e/files/ubs_irl_etf_plc_peit.pdf
The live sheet, always up to date
rebalix.com/en/etf/IE000TB15RC6
Series, distributions, holdings and documents refresh daily.
Sheet produced on 20 October 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · WRDE · IE000TB15RC62